IL73734A - Process for purifying factor viii:c - Google Patents

Process for purifying factor viii:c

Info

Publication number
IL73734A
IL73734A IL73734A IL7373484A IL73734A IL 73734 A IL73734 A IL 73734A IL 73734 A IL73734 A IL 73734A IL 7373484 A IL7373484 A IL 7373484A IL 73734 A IL73734 A IL 73734A
Authority
IL
Israel
Prior art keywords
factor viii
purifying factor
purifying
purified
conductivity
Prior art date
Application number
IL73734A
Other languages
English (en)
Other versions
IL73734A0 (en
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of IL73734A0 publication Critical patent/IL73734A0/xx
Publication of IL73734A publication Critical patent/IL73734A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IL73734A 1983-12-05 1984-12-05 Process for purifying factor viii:c IL73734A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/557,805 US4508709A (en) 1983-12-05 1983-12-05 Process for purifying factor VIII:C

Publications (2)

Publication Number Publication Date
IL73734A0 IL73734A0 (en) 1985-03-31
IL73734A true IL73734A (en) 1989-09-28

Family

ID=24226953

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73734A IL73734A (en) 1983-12-05 1984-12-05 Process for purifying factor viii:c

Country Status (19)

Country Link
US (1) US4508709A (da)
EP (1) EP0144957B1 (da)
JP (1) JPS60136518A (da)
KR (1) KR850004593A (da)
AT (1) ATE60996T1 (da)
AU (1) AU569129B2 (da)
CA (1) CA1248449A (da)
DE (1) DE3484179D1 (da)
DK (1) DK162896C (da)
ES (1) ES8600690A1 (da)
FI (1) FI844804L (da)
IE (1) IE57644B1 (da)
IL (1) IL73734A (da)
IN (1) IN162586B (da)
MX (1) MX7552E (da)
NO (1) NO167627C (da)
NZ (1) NZ210427A (da)
SG (1) SG14992G (da)
ZA (1) ZA849434B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614795A (en) * 1982-08-05 1986-09-30 University Of Rochester Deglycosylated Human Factor VIII:C
US4650858A (en) * 1983-03-21 1987-03-17 Nordisk Gentofte A/S Concentrate of the antihemophilic factor VIII and a process for producing it
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
GB2178533B (en) * 1985-07-22 1989-07-19 Asahi Chemical Ind Analytical method of enzyme precursors and device therefor
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3826792C1 (da) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De
ES2053684T3 (es) * 1988-11-05 1994-08-01 Octapharma Ag Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
JPH0427865A (ja) * 1989-12-21 1992-01-30 Kurita Water Ind Ltd 血液凝固因子用分離剤およびその製造方法
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat

Also Published As

Publication number Publication date
NO167627B (no) 1991-08-19
JPH0535159B2 (da) 1993-05-25
SG14992G (en) 1992-04-16
US4508709A (en) 1985-04-02
AU569129B2 (en) 1988-01-21
JPS60136518A (ja) 1985-07-20
DK575184D0 (da) 1984-12-04
IL73734A0 (en) 1985-03-31
NO844837L (no) 1985-06-06
AU3598284A (en) 1985-06-13
ES538912A0 (es) 1985-11-01
CA1248449A (en) 1989-01-10
DK575184A (da) 1985-06-06
FI844804L (fi) 1985-06-06
NZ210427A (en) 1988-09-29
EP0144957A2 (en) 1985-06-19
ZA849434B (en) 1985-07-31
FI844804A0 (fi) 1984-12-05
MX7552E (es) 1989-09-25
EP0144957B1 (en) 1991-02-27
DK162896B (da) 1991-12-23
IE843105L (en) 1985-06-05
EP0144957A3 (en) 1987-09-30
ATE60996T1 (de) 1991-03-15
DE3484179D1 (de) 1991-04-04
IE57644B1 (en) 1993-02-10
KR850004593A (ko) 1985-07-25
IN162586B (da) 1988-06-11
NO167627C (no) 1991-11-27
ES8600690A1 (es) 1985-11-01
DK162896C (da) 1992-05-11

Similar Documents

Publication Publication Date Title
ZA849434B (en) Process for purifying factor viii:c
DE3467751D1 (en) Process for the treatment of glycerine by distillation
EP0191893A3 (en) Process for adsorption treatment of dissolved fluorine
FR2554827B1 (fr) Procede d'activation de la bioreactivite des microorganismes
PT69305A (en) Process for sorption of gases
DE3064133D1 (en) Purification of human growth hormone
IT1224144B (it) Procedimento per il trattamento dei tessili
FR2590774B1 (fr) Procede ameliore de gonflement du tabac
GB2015531B (en) Purification of bordetella proteins by chromatography
EP0209786A3 (en) Process for purifying human tumour necrosis factor
HK57092A (en) Treatment of high protein oedemas by direct application of benzo-pyrones
YU118183A (en) Process for producing derivatives of condensed as-triazine
EP0185249A3 (en) Process for the purification of crude beta-phenylethyl alcohol
FR2575472B1 (fr) Procede de preparation d'hydrogeno- ou d'halogenosilanes
GB2088357B (en) Concentration of alcohol by freeze-separation process
GB8427232D0 (en) Adsorbents for purification of water &c
GB2158112B (en) Treatment process for utilization of rubber wood
ES8503955A1 (es) Procedimiento para separar y purificar interferon por cromatografia
FR2544319B1 (fr) Procede de preparation de l'anhydrovinblastine
JPS5561913A (en) Regeneration method of adsorbent
BG30650A1 (en) Method for purifying of splenitis fksonukleaza
HU175935B (en) Method for purifying sewages by means of biological sorbents
RO89256A2 (ro) Procedeu de preparare a clorurii de p-clorbenzhidril
YU90084A (en) Process for obtaining adsorbent for effective hydrogen purifying from trace of animal vapours
FR2583041B1 (fr) Procede de purification du pentachlorophenol technique

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired